| Authors: |
Prado-Acosta M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Jeong S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Utrero-Rico A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Goncharov T; Immunology Discovery, Genentech, South San Francisco, CA 94080, USA., Webster JD; Department of Pathology, Genentech, South San Francisco, CA 94080, USA., Holler E; Department of Hematology and Oncology, University of Regensburg, Regensburg 93042, Germany., Morales G; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Dellepiane S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Levine JE; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Rothenberg ME; Early Clinical Development, Genentech, South San Francisco, CA 94080, USA., Vucic D; Immunology Discovery, Genentech, South San Francisco, CA 94080, USA., Ferrara JLM; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. |